Skip to main content
. 2020 Aug 14;12(8):769. doi: 10.3390/pharmaceutics12080769

Figure 1.

Figure 1

Stability study of the formulations with and without 0.2% NOR (w/v) in terms of size (A), PDI (B), and zeta potential (C) during 6 months of storage at 4 °C, n = 3. Statistical methods ANOVA/Tukey were used; * = p < 0.05.